Price analysis of tazetostat in 2025: How do patients plan treatment costs?

Tazemetostat is an epigenetic targeted therapy drug, mainly used to treat relapsed/refractory follicular lymphoma (FL) (non-Hodgkin lymphoma) (non-Hodgkin lymphoma) and epithelioid sarcoma (ES) (soft tissue sarcoma) with EZH2 mutation-positive or EZH2 wild-type. As the world's first EZH2 inhibitor, it inhibits the activity of EZH2 enzyme and prevents the proliferation of cancer cells, bringing new hope to relapsed or refractory patients.

Because tazerestat is a new generation of targeted drug, its research and development costs are high and there is less market competition, so it is relatively expensive. At present, the original drug is produced by Epizyme Company and has been launched in Hong Kong, China, the United States, Japan and Europe. According to overseas market prices, the price of tazerestat200mg*56 capsules per box is between 15,000 and 20,000 RMB.

On March 21, 2025, tazetostat was approved for marketing by the China National Medical Products Administration. However, since new drugs usually need to go through medical insurance negotiations after entering the market, the final pricing in the domestic market has not yet been announced, and the medical insurance reimbursement situation is also unclear. For patients, they may still need to purchase through overseas channels in the short term.

Currently, Laos has launched a generic version of tazerestat, which has the same ingredients as the original drug and is relatively cheap. The price of the Lao version of tazerestat200mg*56 tablets is about 4,000-5,000 yuan, which is much lower than the original drug and is suitable for patients with limited budget. In addition, some pharmaceutical companies will launch assistance programs to provide low-cost or free drugs to eligible patients. It is recommended that patients consult their attending physician or relevant public welfare organizations to obtain the latest assistance information.

For patients who cannot wait for the implementation of medical insurance in the short term, they can purchase original drugs through formal cross-border medical institutions or overseas drug purchasing platforms. However, you need to be wary of informal channels to avoid buying fake or illegal drugs.

Reference materials:https://www.tazverik.com/